8-KLeadership ChangesCorporate ChangesExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K Report, Executive Changes (Jan 4, 2005)

Filed January 4, 2005For Securities:BMYCELG-RIBMYMP

Summary

Bristol Myers Squibb announced significant changes to its Board of Directors and corporate governance structure on January 3, 2005. The company elected James M. Cornelius, non-executive chairman of Guidant Corporation, to its Board, effective immediately. Mr. Cornelius will be subject to shareholder election at the May 2005 Annual Meeting. His appointment is a notable addition to the board's expertise and oversight capabilities. Furthermore, the company amended its Bylaws to increase the size of the Board of Directors from ten to eleven members. This change, effective January 3, 2005, provides the board with greater flexibility in its composition and potentially allows for the inclusion of more diverse skill sets to guide the company's strategic direction and governance.

Key Highlights

  • 1Appointment of James M. Cornelius to the Board of Directors.
  • 2James M. Cornelius currently serves as non-executive chairman of Guidant Corporation.
  • 3Mr. Cornelius's election is effective January 3, 2005.
  • 4Mr. Cornelius will stand for election by stockholders at the May 2005 Annual Meeting.
  • 5Board of Directors size increased from ten to eleven members.
  • 6Amendment to Bylaws to reflect the increased board size was effective January 3, 2005.
  • 7The press release announcing the director election is attached as an exhibit.

Frequently Asked Questions

James M. Cornelius is currently the non-executive chairman of Guidant Corporation. His appointment to the Bristol Myers Squibb Board of Directors, effective January 3, 2005, likely brings valuable industry experience and leadership perspective to the company's governance. He will be up for shareholder election in May 2005.

The increase in the Board of Directors from ten to eleven members provides Bristol Myers Squibb with enhanced flexibility. This change can allow for the inclusion of directors with specialized expertise or different backgrounds, potentially strengthening the board's oversight, strategic guidance, and overall effectiveness in navigating complex business challenges.

The filing explicitly states that Mr. Cornelius was not elected pursuant to any arrangement or understanding between him and any other persons, indicating his appointment is independent and not tied to any specific undisclosed agreements.